{
    "summary": "The 'Patient Access to Autoimmune Treatments Act' (PAAT Act) amends Title XVIII of the Social Security Act to mandate Medicare Part D coverage for drugs treating autoimmune diseases, hemophilia, and Von Willebrand disease. Starting in 2027, PDP sponsors must include these drugs. The bill also restricts prior authorization requirements for these drugs, permitting it only once every 12 months unless specific conditions are met, such as the drug's short-term use or categorization.",
    "tags": [
        "Healthcare",
        "Social security",
        "Healthcare access",
        "Elderly care",
        "Opioid crisis"
    ],
    "category": "Healthcare & Public Health"
}